GenEditBio - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeGenEditBio
GenEditBio logo

GenEditBio

0 followers

About GenEditBio

GenEditBio is a clinical-stage biotechnology company focused on CRISPR-based precision genome editing therapies. The company aims to deliver affordable, in-body “DNA surgery” to treat genetic diseases with unmet medical needs, using novel Cas nucleases and safe cargo delivery via lipid nanoparticles (LNPs) and engineered protein delivery vehicles (PDVs). Its pipeline targets in vivo genome-editing applications across ocular, metabolic, and rare diseases, with the goal of curing genetic conditions at their roots. Headquarters and research activities are based in Hong Kong and Beijing, reflecting its global development footprint.

Recent News

Recent Deals

No recent deals for this company.

Key Team Members

Kunwoo (Ryan) Lee, Ph.D.

Chief Executive Officer & Co-founder

Hyo Min (Huey) Park, Ph.D.

Chief Operating Officer & Co-founder

Seokjoong (SJ) Kim, Ph.D.

Chief Strategy Officer

Jeff Kang, CPA

Chief Financial Officer

Timothy Fong, Ph.D., MBA

Chief Technology Officer

Key Facts

HQ Location

Hong Kong S.A.R.

Founded

2021

Employees

11 - 50

Status

Private

Website

https://geneditbio.com